NeueHealth, Inc. (NYSE:NEUE – Get Free Report) CFO Jay Matushak sold 1,860 shares of the business’s stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $7.19, for a total value of $13,373.40. Following the sale, the chief financial officer now owns 22,227 shares of the company’s stock, valued at $159,812.13. The trade was a 7.72 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.
Jay Matushak also recently made the following trade(s):
- On Monday, January 6th, Jay Matushak sold 4,970 shares of NeueHealth stock. The stock was sold at an average price of $7.33, for a total value of $36,430.10.
NeueHealth Stock Up 0.3 %
Shares of NYSE:NEUE opened at $6.92 on Wednesday. The business has a fifty day moving average of $7.33 and a two-hundred day moving average of $5.99. The stock has a market cap of $57.33 million, a P/E ratio of -0.14 and a beta of 0.56. NeueHealth, Inc. has a 52-week low of $3.79 and a 52-week high of $8.32.
Institutional Trading of NeueHealth
Analysts Set New Price Targets
Separately, Royal Bank of Canada dropped their target price on NeueHealth from $8.00 to $7.00 and set a “sector perform” rating for the company in a report on Monday, December 9th.
Read Our Latest Analysis on NeueHealth
About NeueHealth
NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.
Further Reading
- Five stocks we like better than NeueHealth
- Want to Profit on the Downtrend? Downtrends, Explained.
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- Stock Market Upgrades: What Are They?
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.